Free press releases distribution network?

Agency / Source: Comago

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



OrganoBalance to Present its Latest Research Findings at ACHEMA 2012 - Increasing the potential for yeast strains in biotech manufacturing - OrganoBalance.com
OrganoBalance to Present its Latest Research Findings at ACHEMA 2012

 

PRZOOM - /newswire/ - Falkensee, Brandenburg, Germany, 2012/06/13 - Increasing the potential for yeast strains in biotech manufacturing - OrganoBalance.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

At this year's ACHEMA (Frankfurt, 18 to 22 June), the Berlin-based biotech company OrganoBalance GmbH will present its most recent findings on the potential uses of yeast strains in the biotechnological production of fine chemicals and new ingredients for pharmaceuticals, cosmetics, foods or feedstuffs (metabolic engineering of yeasts).

In his talk, The yeast Saccharomyces cerevisiae as platform organism for the biotechnological production of miscellaneous industrial relevant compounds, Dr Andreas Raab, Director Research at OrganoBalance, will provide a comprehensive outline of the said topic (22 June at 12.30 pm in hall 9.1, room Esprit).

Prof. Christine Lang, the company's founder and CEO, will focus on newly developed products in the field of specific probiotic microorganisms during her talk, Lactobacilli and yeasts - new ways with old friends, as part of the session Food biotechnology - Whole cells (21 June at 11.30 am in hall 4C, room Consens). When pursuing new developments in this field, OrganoBalance can draw on the potential of its own collection of more than 8,000 natural yeasts and lactic acid bacteria.

“Our unparalleled expertise in the metabolic engineering of yeasts has enabled us to greatly increase the efficiency and sustainability of a number of our partners' manufacturing processes, as well as develop completely new methods”, Dr Raab explains.

Prof. Lang adds: “We're looking forward to ACHEMA, along with the opportunity to share our latest research results and visions with a wider audience. New manufacturing technologies and processes will continue to change the face of biotechnology with lightning speed. OrganoBalance has long been actively involved in such developments, and will remain so in the future.”

Visitors interested in further information on current projects are welcome to visit OrganoBalance at the communal booth of the VBU Association of German Biotechnology Companies, stand C62 in hall 9.2. Appointments can be made online.

About OrganoBalance
OrganoBalance GmbH (organobalance.com) is a company specialising in microbiological strain development. The company targets the use of Saccharomyces cerevisiae yeast strains for synthesising materials which can be applied in the processes of industrial and pharmaceutical biotechnology. OrganoBalance also taps the potential of beneficial microorganisms, known as specific probiotic cultures, in order to balance out microflora in a natural way and restore the microbial equilibrium.

By drawing on its own collection of microorganisms suitable for use in foodstuffs, as well as its own OASSYS® screening systems, OrganoBalance develops new biological products in the areas of pharmaceutics, preventive healthcare, nutrition and cosmetics. OrganoBalance was founded in 2001 and is based in Berlin, Germany.

Further information:

OrganoBalance GmbH
Kristin Ebert
Gustav-Meyer-Allee 25
13355 Berlin
Germany
T: +49 (0) 30 46307-200 / F: +49 (0) 30 46307-210
E: info[.]organobalance.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Comago

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


OrganoBalance to Present its Latest Research Findings at ACHEMA 2012

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Helmut Landenberger - Comago.de 
+49 33 22 84 06 52 landenberger[.]comago.de
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Comago securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Comago / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today